Clinical Trial

Prospective G7 Dual Mobility Total Hip PMCF

Active, Not Recruiting
View on ClinicalTrials.gov →
Summary
This is a prospective multi-center clinical evaluation following recipients of the G7 Dual Mobility hip device. The primary objective is to characterize survivorship of the G7 hip at five years post-index procedure. Secondary objectives include documentation of clinical outcomes, safety and radiographic data.
Protocol Amendment History 11 amendments
This ClinicalTrials.gov record has been amended 11 times since 2017-10-06; most recent amendment 2025-06-13.
Status change: Enrolling by Invitation → Active, Not Recruiting 2023-07-10
Trial Details
NCT Number NCT03308929
Lead Sponsor Zimmer Biomet
Conditions Clinical Outcomes, Functional Outcomes, Radiological Outcomes, Survivorship, Safety
Enrollment 250 participants
Start Date 2017-02-28
Primary Completion 2027-07-01 (estimated)
Study Completion 2029-02-28 (estimated)
Updated on ClinicalTrials.gov 2025-06-15